These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2506950)

  • 1. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
    Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
    Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
    Vrana JA; Rao AS; Wang Z; Jarvis WD; Grant S
    Int J Oncol; 1998 Apr; 12(4):927-34. PubMed ID: 9499457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
    Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
    Drexler HG; Gignac SM; Pettit GR; Hoffbrand AV
    Eur J Immunol; 1990 Jan; 20(1):119-27. PubMed ID: 1689659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
    Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
    Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
    Mackanos EA; Pettit GR; Ramsdell JS
    J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
    Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
    Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic action of calcium ionophore A23187 and phorbol ester TPA on B-chronic lymphocytic leukemia cells.
    Drexler HG; Brenner MK; Coustan-Smith E; Wickremasinghe RG; Hoffbrand AV
    Blood; 1987 Nov; 70(5):1536-42. PubMed ID: 3117134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
    Battle TE; Frank DA
    Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
    Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
    Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
    Gartenhaus R; Hoffman M; Fuchs A; Billet H; Wang P; Gentile P; Rai K
    Leuk Lymphoma; 1996 Jun; 22(1-2):97-101, follow.186, color plate IX. PubMed ID: 8724534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.
    Gignac SM; Buschie M; Pettit GR; Hoffbrand AV; Drexler HG
    Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells.
    Boorne AJ; Donnelly N; Schrey MP
    Breast Cancer Res Treat; 1998 Mar; 48(2):117-24. PubMed ID: 9596483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid expression of protooncogenes c-fos and c-myc in B-chronic lymphocytic leukemia cells during differentiation induced by phorbol ester and calcium ionophore.
    Drexler HG; Janssen JW; Brenner MK; Hoffbrand AV; Bartram CR
    Blood; 1989 May; 73(6):1656-63. PubMed ID: 2496772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-induction of lymphokine synthesis by the antineoplastic bryostatins.
    Mohr H; Pettit GR; Plessing-Menze A
    Immunobiology; 1987 Nov; 175(5):420-30. PubMed ID: 3123367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ; Prestigiacomo LJ; Tyler G; May WS; Davidson NE
    Cancer Res; 1992 Mar; 52(5):1278-83. PubMed ID: 1737390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro beta 2-microglobulin (beta 2m) secretion by normal and leukaemic B-cells: effects of recombinant cytokines and evidence for a differential response to the combined stimulus of phorbol ester and calcium ionophore.
    Jones RA; Drexler HG; Gignac SM; Child JA; Scott CS
    Br J Cancer; 1990 May; 61(5):675-80. PubMed ID: 2110813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.